Health

AstraZeneca withdraws Swiss application for coronavirus vaccine

Published

3 years ago

November 4, 2021

Ummul Idris

British pharmaceutical company AstraZeneca has withdrawn its application for approval of its coronavirus vaccine in Switzerland.

The company said on Thursday that it withdrew it’s application after Swiss authorities indicated that it would only be cleared for use in people aged 50 and older.

AstraZeneca filed its application to Swissmedic in October 2020.

There has been regular contact between the company and the regulators since.

Swissmedic had repeatedly said that it was lacking sufficient data to approve the drug for broad use.

The country originally ordered 5.3 million doses of AstraZeneca vaccine, but has passed on 440,000 of those to a group of five developing countries while the wait for approval dragged on.

Related Topics:

Up Next

Fashola craves more investment in medical research at NIMR foundation fund raising

Don't Miss

Workers shut down ABSUTH indefinitely over 22 months salary arrears

Ummul Idris

NEWSVERGE, published by The Verge Communications is an online community of international news portal and social advocates dedicated to bringing you commentaries, features, news reports from a Nigerian-African perspective. A unique organization, founded in the spirit of Article 19 of the Universal Declaration of Human Rights, comprising of ordinary people with an overriding commitment to seeking the truth and publishing it without fear or favour. The Verge Communications is fully registered with the Corporate Affairs Commission of the Federal Republic of Nigeria as a corporate organization.